Page 96 - Sohini Das

Domestic pharmaceutical industry to clock 4-6% growth in FY21: Icra

The domestic pharma industry has been posting slow growth numbers since March after the Covid-19 pandemic hit prescription generation

Dr Reddy's to launch Covid drugs remdesivir and favipiravir in August

Trying to boost acquired Wockhardt portfolio which saw sharp decline in sales during pandemic

Hetero joins long list of firms to launch Covid-19 drug favipiravir

Will sell its oral anitiviral for Rs 59 a pill, Cipla and DRL to launch soon

Trailing in the value chain: Domestic pharma's unfinished agenda

In the first of a 5-part series, we look at reasons keeping Indian pharma sector from becoming the best globally

Lessons learnt: Delhi, Mumbai show the way on how to tame the Covid curve

The drop in the curve, experts say, is partially because of the pandemic playing itself out, and partially because of the two cities finally getting their act together

Covid-19: Favipiravir triggers a price war; new brand launched at Rs 39

According to industry insiders, many more brands are lined up for launch, including one from Cipla

Adar Poonawalla: A rare risk-taking CEO with strong business acumen

Adar Poonawalla's Serum Institute has tied up with AstraZeneca-backed Oxford vaccine candidate for one billion doses which it will make for India and the GAVI vaccine alliance of 58 countries

Covid-19: Testing times for plasma banks as demand goes through the roof

The first of a two-part series looks at challenges involved in plasma therapy

Covid-19 crisis: Plasma transfusion is adjunct treatment; timing is key

The second of a two-part series looks at how effective plasma therapy is in the fight against Covid-19

Covid-19 crisis: Briton Pharma gets DCGI nod to launch favipiravir

Pune-based Brinton Pharmaceuticals said on Thursday it had got the nod from the Drugs Controller General of India (DCGI) to market its brand Faviton, priced at Rs 59 per tablet

Cheaper favipiravir brand gets nod, to enter market at Rs 59 a pill

The product comes Pune-based Brinton Pharma; Glenmark's FabiFlu is priced at Rs 73 a tablet

MyLab Discovery Solutions' Covid-19 antigen testing kits get ICMR nod

MyLab's kit named 'Pathocatch' will be available for orders immediately and will be priced at around Rs 450

Covid-19 crisis: Glenmark claims 'clinical cure in 4 days' in Phase-3 trial

Firm claims trial results showed 28.6% faster viral clearance in overall population, says drug well tolerated with no major side effects

Govt notifies incentive scheme for local API manufacturing to cut imports

According to a government notification, bulk drugs accounted for 63 per cent of total pharmaceutical imports in the country in 2018-19.

We want to price Covid-19 vaccine below Rs 1,000: Serum Institute CEO

Pune's Serum Institute of India is placing its bets on the Oxford-AstraZeneca vaccine candidate AZD1222

FabiFlu cheaper than other drugs to treat Covid-19, claims Glenmark

The company further claimed that since favipiravir was an oral therapy, patients could be treated on an out-patient basis without incurring additional hospitalisation expenses

Covid-19 treatment: A lowdown on possible cure and drugs being used

Business Standard takes a look at the common drugs that are being used in India for treating Covid-19 patients

Glenmark under fire for over pricing, 'misguided' claims of Covid-19 drug

NCP legislator Amol Kolhe's letter to Health Minister Harsh Vardhan triggers the DCGI to seek details from the Mumbai-based drugmaker

Covid-19: Vaccine firms give Moderna a shrug, say no rush on tie-ups

Most players that Business Standard spoke to said they would be concentrating on their own vaccine candidates or the current tie-ups that they have

Covid-19 crisis: Race to develop vaccine gets a booster as field widens

On Thursday, CDSCO also approved Zydus Cadila's plasmid DNA vaccine candidate ZyCoV-D, developed at its Vaccine Technology Centre in Ahmedabad.